Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: Multicenter phase II trial-Reference-Cited by-同舟云学术

Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: Multicenter phase II trial

Published:2007-06 Issue:3 Volume:56 Page:371-376
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Araya Tomoyuki,Kasahara Kazuo,Kimura Hideharu,Shibata Kazuhiko,Kita Toshiyuki,Shirasaki Hiroki,Hara Johsuke,Yoshimi Yuzo,Sone Takashi,Oribe Yoshitaka,Nobata Kouichi,Nishi Kouichi,Fujimura Masaki,Nakao Shinji

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Foundation for Promotion of Cancer Research. Cancer Statistics in Japan 2003. The Editorial Board of the Cancer Statistics in Japan, 2003.

2. Polychemotherapy in advanced non-small-cell lung cancer: a meta-analysis;Souquet;Lancet,1993

3. Chemotherapy in non-small cell lung cancer: a meta analysis using updated data on individual patients from 52 randomized clinical trials;Br Med J,1995

4. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions;Oshita;Jpn J Cancer Res,1995

5. Prevalence of comorbidity in lung cancer patients and its relationship with treatment: a population-based study;Maryska;Lung Cancer,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine Plus Vinorelbine as the Second-Line Treatment and Beyond in Elderly Patients with Platinum-Pretreated Advanced Non-Small Cell Lung Cancer;Chemotherapy;2015-04-28

2. Gemcitabine and Vinorelbine (GemVin) Regimen;Hospital Pharmacy;2014-06

3. Cytology-based treatment decision in primary lung cancer: Is it accurate enough?;Lung Cancer;2012-03

4. Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study;Lung Cancer;2009-01